Koninklijke DSM N.V.
KDSKF · OTC
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.27 | 18.45 | 0.17 | -3.05 |
| FCF Yield | 0.11% | 0.81% | 1.29% | 1.77% |
| EV / EBITDA | 79.44 | 28.47 | 48.41 | 36.17 |
| Quality | ||||
| ROIC | -3.06% | 3.62% | 6.20% | 4.46% |
| Gross Margin | 20.67% | 32.06% | 34.38% | 34.25% |
| Cash Conversion Ratio | 0.25 | 0.56 | 0.85 | 2.94 |
| Growth | ||||
| Revenue 3-Year CAGR | -6.22% | 1.15% | 0.71% | -4.36% |
| Free Cash Flow Growth | -91.72% | -63.06% | -2.07% | 16.67% |
| Safety | ||||
| Net Debt / EBITDA | 3.05 | 0.22 | 1.10 | 1.89 |
| Interest Coverage | -2.92 | 5.25 | 9.28 | 6.76 |
| Efficiency | ||||
| Inventory Turnover | 2.60 | 2.44 | 2.63 | 2.84 |
| Cash Conversion Cycle | 144.54 | 126.64 | 107.76 | 109.21 |